Source: Cancer Letters. Unidades: FMRP, FCFRP
Subjects: FÁRMACOS, OBESIDADE (TRATAMENTO), CARCINÓGENOS QUÍMICOS, CÓLON
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GARCIA, Sérgio Britto et al. The anti-obesity agent Orlistat is associated to increase in colonic preneoplastic markers in rats treated with a chemical carcinogen. Cancer Letters, v. 240, n. 2, p. 221-224, 2006Tradução . . Disponível em: https://doi.org/10.1016/j.canlet.2005.09.011. Acesso em: 05 nov. 2024.APA
Garcia, S. B., Barros, L. T. da C., Turatti, A., Martinello, F., Modiano, P., Ribeiro-Silva, A., et al. (2006). The anti-obesity agent Orlistat is associated to increase in colonic preneoplastic markers in rats treated with a chemical carcinogen. Cancer Letters, 240( 2), 221-224. doi:10.1016/j.canlet.2005.09.011NLM
Garcia SB, Barros LT da C, Turatti A, Martinello F, Modiano P, Ribeiro-Silva A, Vespúcio MV de O, Uyemura SA. The anti-obesity agent Orlistat is associated to increase in colonic preneoplastic markers in rats treated with a chemical carcinogen [Internet]. Cancer Letters. 2006 ; 240( 2): 221-224.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1016/j.canlet.2005.09.011Vancouver
Garcia SB, Barros LT da C, Turatti A, Martinello F, Modiano P, Ribeiro-Silva A, Vespúcio MV de O, Uyemura SA. The anti-obesity agent Orlistat is associated to increase in colonic preneoplastic markers in rats treated with a chemical carcinogen [Internet]. Cancer Letters. 2006 ; 240( 2): 221-224.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1016/j.canlet.2005.09.011
